WTP2.6 Early experience and short-term outcomes of Robotic Assisted adrenalectomy in a high volume tertiary referral centre

Abstract

Abstract Aim Robotic assisted surgery has become the standard of care in most surgical specialties, however, in the UK, endocrine surgery has not fully adopted robotics. This paper presents the experience in seventeen (17) patients who had robotic assisted adrenalectomies performed at a tertiary referral endocrine surgery department in the northeast of England. Outcomes were compared to national and international performance standards. Methods Seventeen elective cases were performed at tertiary hospital over a 5-month period. Patient demographics including age, comorbidities, operative indications and technical details such as docking time, time on operative console, rates of conversion to open procedure, complications, length of stay and tumour size were analysed. Results Over a 5-month period, 17 robotic assisted adrenalectomies were performed. Seventy-one percent (71%) (n=12) of the patients were female with median age of 60 years. Median BMI was 28. Functional tumours accounted for 82%(n=14) of patients with the most common being pheochromocytomas and cortisol producing adenomas (n=6 respectively). Median docking time was 7 minutes with a median intra-operative time on the console of 48 minutes. Resected tumour size ranged between 1cm to 14cm. There were no conversions, complications or mortalities. Median length of stay postoperatively was 1 day. Conclusion This cases series demonstrates robotic assisted adrenalectomies to be a safe and feasible approach with similar outcomes to laparoscopic surgery. Adoption of robotic assisted surgery will improve outcomes for patients, however large clinical trials and longer follow up are needed.